GrapheneOS, a privacy-first, open-source mobile operating system, is expanding beyond Google Pixels to support Motorola smartphones next year. The GrapheneOS Foundation, which develops the OS, wrote on Mastodon that initial support will begin with traditional flagship devices before reaching foldable models, like the Motorola Razr Fold. GrapheneOS has rigorous security standards, which it said many
Australian audio brand RØDE has released the DS3, its next-generation professional desktop studio arm, designed to handle the heavier gear now common on creator desks. The DS3 builds directly on the popular DS2 and raises the maximum payload from around 900g to 1.5kg. That increase opens the door to broadcast-style XLR microphones, larger-diaphragm condensers, cameras,
The investigation seeks to determine whether OpenAI’s safety practices violated state consumer protection laws and pose a risk to Alabama citizens, the AG’s office said in a statement. “This AI lab leak showed that Alabamians’ and Americans’ worst fears about artificial intelligence are not just theoretical,” said Attorney General Steve Marshall. “Our investigation seeks to
Three years ago, Andrew Stockwell had his hiring routine down to a science. As head of people for the software-buying company Vendr, Stockwell posted a listing, waited a few days, and then reviewed a few dozen applications—up to 100, if he was lucky. Recruiters identified other potential candidates, adding a few more applicants to the
Oura, the smart ring maker, with offices in San Francisco and Finland, is reportedly planning to raise up to $3 billion as soon as next month in a U.S. IPO that values the more than 900-person company at [spits out coffee] north of $16 billion, according to Bloomberg. The outlet adds that investors are expected
We live in a time when mixed messages about vaccines are the norm. Often, the Trump administration says one thing, while public health officials say another, leaving at least half of Americans in what the independent health policy organization KFF called the “malleable middle.” They remain uncertain when presented with vaccine myths. To address the